PER 5.26% 8.0¢ percheron therapeutics limited

antisense gen2 reduction drugs!!, page-21

  1. 2,315 Posts.
    lightbulb Created with Sketch. 11
    Thanks all...

    Nikolal, as you say one of the better things to come out of all of this is that sufferers of the diseases these drugs treat are getting a better quality of life, and in cases avoiding premature death.

    When a bio like ANP has success it fast becomes a win/win for all those involved both medically as well as financially... and we shouldn’t lose sight of that.

    ANP will grow bigger on the back of their success with ATL1103... and in turn they will be able take on further developments of different antisense drugs that will treat many previously unmet illnesses and markets

    i can only see this getting much, much bigger from here.

    Today’s trading had the feeling of realisation about it... big buyers and lots of them.

    Still there is much more value than the market has priced in so far. You only need to put the pieces of the jigsaw puzzle together to see we are on the cusp of adding such significant value that these are very much giveaway prices before us today.



    JMO, and Good Luck!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.004(5.26%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $35.48K 451.2K

Buyers (Bids)

No. Vol. Price($)
1 12500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 198147 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.